Vivian Salama, Assistant Professor at WVU Cancer Institute, shared on LinkedIn:
“I am very glad that finally my Master’s degree project has been accepted for publication at Blood Cancer Discovery in a very big paper in collaboration with Elli Lilly and Company Team.
I am grateful to Nathan the main scientist of this work, and to Anna my first research supervisor and to Dr. Konopleva my primary mentor and my love. I am also very grateful to be included as equal contribution with the first author Nathan, Anna and Mark.
That’s a big privilege.”
Title: LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models
Authors: Nathan A. Brooks, Anna Skwarska, Vivian Salama, Mark H. Bender, Lisa Kays, Robin I. DeWalt, Bryan Perria, Deepti Thete, Jason R. Manro, Rachel Cavitt, Rebecca Leon, Sandra Gomez, Raquel Torres, John M. Strelow, Paul Milligan, Kate Newell, Kenneth D. Roth, Jean-Emmanuel Sarry, Steven M. Chan, Danalyn Manglicmot Lagutan, Richard Romero, Stephen Antonysamy, Robert L. Johnson, Xueqian Gong, Renato A. Bauer, Timothy P. Burkholder, Patric J. Hahn, Zoran Rankovic, Serge L. Boulet, Courtney D. DiNardo, Marina Konopleva, Raymond Gilmour
Read the Full Article
